This additional European patent will further strengthen Salipro Biotech’s integrated IP portfolio protecting its proprietary Salipro® platform technology to stabilize challenging drug targets and enable the discovery and development of next-generation therapeutics. STOCKHOLM, March 14,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.